BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18663361)

  • 1. Pituitary tumor transforming gene 1 regulates Aurora kinase A activity.
    Tong Y; Ben-Shlomo A; Zhou C; Wawrowsky K; Melmed S
    Oncogene; 2008 Oct; 27(49):6385-95. PubMed ID: 18663361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms for growth factor-induced pituitary tumor transforming gene-1 expression in pituitary folliculostellate TtT/GF cells.
    Vlotides G; Cruz-Soto M; Rubinek T; Eigler T; Auernhammer CJ; Melmed S
    Mol Endocrinol; 2006 Dec; 20(12):3321-35. PubMed ID: 16959877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary tumor transforming gene interacts with Sp1 to modulate G1/S cell phase transition.
    Tong Y; Tan Y; Zhou C; Melmed S
    Oncogene; 2007 Aug; 26(38):5596-605. PubMed ID: 17353909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTTG1 attenuates drug-induced cellular senescence.
    Tong Y; Zhao W; Zhou C; Wawrowsky K; Melmed S
    PLoS One; 2011; 6(8):e23754. PubMed ID: 21858218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDAC and Hsp90 inhibitors down-regulate PTTG1/securin but do not induce aneuploidy.
    Hernández A; López-Lluch G; Navas P; Pintor-Toro JA
    Genes Chromosomes Cancer; 2009 Feb; 48(2):194-201. PubMed ID: 19006077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FoxM1 transactivates PTTG1 and promotes colorectal cancer cell migration and invasion.
    Zheng Y; Guo J; Zhou J; Lu J; Chen Q; Zhang C; Qing C; Koeffler HP; Tong Y
    BMC Med Genomics; 2015 Aug; 8():49. PubMed ID: 26264222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F1 induces pituitary tumor transforming gene (PTTG1) expression in human pituitary tumors.
    Zhou C; Wawrowsky K; Bannykh S; Gutman S; Melmed S
    Mol Endocrinol; 2009 Dec; 23(12):2000-12. PubMed ID: 19837943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-329-mediated PTTG1 downregulation inactivates the MAPK signaling pathway to suppress cell proliferation and tumor growth in cholangiocarcinoma.
    Hu ZG; Zheng CW; Su HZ; Zeng YL; Lin CJ; Guo ZY; Zhong FD; Yuan GD; He SQ
    J Cell Biochem; 2019 Jun; 120(6):9964-9978. PubMed ID: 30582202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases.
    Crosio C; Fimia GM; Loury R; Kimura M; Okano Y; Zhou H; Sen S; Allis CD; Sassone-Corsi P
    Mol Cell Biol; 2002 Feb; 22(3):874-85. PubMed ID: 11784863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the pituitary tumor transforming gene 1 in the progression of hepatocellular carcinoma.
    Liang M; Chen X; Liu W; Li S; Li C; Jiang L; Lv S
    Cancer Biol Ther; 2011 Feb; 11(3):337-45. PubMed ID: 21099350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aurora A, Aurora B and survivin are novel targets of transcriptional regulation by histone deacetylase inhibitors in non-small cell lung cancer.
    Zhang XH; Rao M; Loprieato JA; Hong JA; Zhao M; Chen GZ; Humphries AE; Nguyen DM; Trepel JB; Yu X; Schrump DS
    Cancer Biol Ther; 2008 Sep; 7(9):1388-97. PubMed ID: 18708766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis.
    Bernal JA; Luna R; Espina A; Lázaro I; Ramos-Morales F; Romero F; Arias C; Silva A; Tortolero M; Pintor-Toro JA
    Nat Genet; 2002 Oct; 32(2):306-11. PubMed ID: 12355087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of the pituitary tumor transforming gene induces p53-dependent senescence through activating DNA damage response pathway in normal human fibroblasts.
    Hsu YH; Liao LJ; Yu CH; Chiang CP; Jhan JR; Chang LC; Chen YJ; Lou PJ; Lin JJ
    J Biol Chem; 2010 Jul; 285(29):22630-8. PubMed ID: 20452981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid hormone receptors suppress pituitary tumor transforming gene 1 activity in hepatoma.
    Chen RN; Huang YH; Yeh CT; Liao CH; Lin KH
    Cancer Res; 2008 Mar; 68(6):1697-706. PubMed ID: 18339849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary tumor-transforming 1 increases cell motility and promotes lymph node metastasis in esophageal squamous cell carcinoma.
    Ito T; Shimada Y; Kan T; David S; Cheng Y; Mori Y; Agarwal R; Paun B; Jin Z; Olaru A; Hamilton JP; Yang J; Abraham JM; Meltzer SJ; Sato F
    Cancer Res; 2008 May; 68(9):3214-24. PubMed ID: 18451147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pttg1/securin is required for the branching morphogenesis of the mammary gland and suppresses mammary tumorigenesis.
    Hatcher RJ; Dong J; Liu S; Bian G; Contreras A; Wang T; Hilsenbeck SG; Li Y; Zhang P
    Proc Natl Acad Sci U S A; 2014 Jan; 111(3):1008-13. PubMed ID: 24395789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dicoumarol down-regulates human PTTG1/Securin mRNA expression through inhibition of Hsp90.
    Hernández A; López-Lluch G; Bernal JA; Navas P; Pintor-Toro JA
    Mol Cancer Ther; 2008 Mar; 7(3):474-82. PubMed ID: 18347135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of Aurora B kinase induces cellular senescence in human fibroblasts and endothelial cells through a p53-dependent pathway.
    Kim HJ; Cho JH; Quan H; Kim JR
    FEBS Lett; 2011 Nov; 585(22):3569-76. PubMed ID: 22024481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromatin-associated protein phosphatase 1 regulates aurora-B and histone H3 phosphorylation.
    Murnion ME; Adams RR; Callister DM; Allis CD; Earnshaw WC; Swedlow JR
    J Biol Chem; 2001 Jul; 276(28):26656-65. PubMed ID: 11350965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop.
    Liang HQ; Wang RJ; Diao CF; Li JW; Su JL; Zhang S
    Oncotarget; 2015 Oct; 6(30):29413-27. PubMed ID: 26320179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.